These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8150320)

  • 1. Clinical and pharmacokinetic observations on valproate: a 3 year follow-up study in 100 children with generalized epilepsy.
    Steinborn B; Galas-Zgorzalewicz B
    Funct Neurol; 1993; 8(6):415-22. PubMed ID: 8150320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A single daily dose with valproic acid. A pharmacodynamic and clinical study].
    Pelzl G; Mamoli B
    Wien Klin Wochenschr; 1992; 104(10):286-9. PubMed ID: 1604872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of valproic acid monotherapy on behavior and cognitive performance of children with idiopathic generalized epilepsy].
    Schmidt A; Darius J; Brosz M; Roth N; Meyer FP; Kroker S; Wien F; Brett B
    Z Kinder Jugendpsychiatr; 1995 Sep; 23(3):161-70. PubMed ID: 7571875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid infusion of sodium valproate in acutely ill children.
    Birnbaum AK; Kriel RL; Norberg SK; Wical BS; Le DN; Leppik IE; Cloyd JC
    Pediatr Neurol; 2003 Apr; 28(4):300-3. PubMed ID: 12849885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid clearance in children with epilepsy.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I
    J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmacokinetic optimization of depakin in children with epilepsy].
    Shamansurov ShSh
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(6):37-8. PubMed ID: 7740873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood level profile of valproate administration under therapeutic conditions in children].
    Meyer FP; Sauer I; Staemmler U; Walther H
    Padiatr Grenzgeb; 1990; 29(4):325-30. PubMed ID: 2216528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
    Miró J; Aiguabella M; Veciana M; Juvany R; Santurino M; Leiva E; Salas-Puig J; Falip M
    Acta Neurol Scand; 2014 May; 129(5):e20-3. PubMed ID: 24372179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment and additional disease on pharmacokinetic of valproic acid in children with epilepsy.
    Juárez-Olguín H; Lugo-Goytia G; Flores-Murrieta F; Ruiz-García M; Lares Asseff I; Flores Pérez J
    Rev Invest Clin; 2010; 62(6):516-23. PubMed ID: 21416779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary generalized epilepsy during infancy and early childhood.
    Shahar E; Barak S; Andraus J; Kramer U
    J Child Neurol; 2004 Mar; 19(3):170-4. PubMed ID: 15119477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate.
    Rinnerthaler M; Luef G; Mueller J; Seppi K; Wissel J; Trinka E; Bauer G; Poewe W
    Epilepsia; 2005 Feb; 46(2):320-3. PubMed ID: 15679514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-drug treatment failures in children newly diagnosed with epilepsy.
    Dudley RW; Penney SJ; Buckley DJ
    Pediatr Neurol; 2009 Feb; 40(2):71-7. PubMed ID: 19135617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An experimental design for finding of minimum dosage of carbamazepine and valproate in preventing of seizure attacks.
    Samaei A; Nobahar M; Vafaei AA
    Pak J Pharm Sci; 2009 Apr; 22(2):180-3. PubMed ID: 19339229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
    Boggs JG; Preis K
    Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate reduces spontaneous generalized spikes and waves but not photoparoxysmal reactions in patients with idiopathic generalized epilepsies.
    Muhle H; Ettle E; Boor R; Stephani U; Siniatchkin M
    Epilepsia; 2011 Jul; 52(7):1297-302. PubMed ID: 21480883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC; Diener W; Kutschke G; Schneble HJ; Korinthenberg R; Sutor AH
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of valproate in Mexican children with epilepsy.
    Correa T; Rodríguez I; Romano S
    Biopharm Drug Dispos; 2008 Dec; 29(9):511-20. PubMed ID: 19067436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.